Jan 22 (Reuters) - Shanghai Fosun Pharmaceutical 600196.SS:
SAYS IT PLANS TO BUY BACK 300-600 MILLION YUAN ($41.28-82.57 million) OF COMPANY A-SHARES BETWEEN JAN 22 AND JULY 21
SAYS IT PLANS TO BUY BACK UP TO 27.6 MILLION COMPANY H-SHARES WITHIN SAME PERIOD
SAYS UNIT'S PLAN TO MERGE WITH HENLIUS BIOTECH FAILED TO PASS HENLIUS'S SHAREHOLDER MEETING
Source text
Source text 2
Source text 3
Further company coverage: 600196.SS
($1 = 7.2666 Chinese yuan renminbi)
(Reporting by Beijing Newsroom)
((yukun.zhang@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。